<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03702933</url>
  </required_header>
  <id_info>
    <org_study_id>HerzogHospital</org_study_id>
    <nct_id>NCT03702933</nct_id>
  </id_info>
  <brief_title>D-serine in Schizophrenia</brief_title>
  <acronym>DSRSZ</acronym>
  <official_title>The Effects of Add-On D-serine Pharmacotherapy in Chronic Treatment Resistant Schizophrenia Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herzog Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herzog Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the effects of D-serine adjuvant treatment to the ongoing
      pharmacological treatment of schizophrenia patients that are resistant to treatments.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PANSS Total Score</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <description>starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose</arm_group_label>
    <description>3.5 g/d D-serine adjuvant treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Dose</arm_group_label>
    <description>2.1 g/d D-serine adjuvant treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D-serine</intervention_name>
    <description>dosage</description>
    <arm_group_label>High Dose</arm_group_label>
    <arm_group_label>Low Dose</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        schizophrenia patients that do not respond to their treatments
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-5 Schizophrenia criteria, able and willing to give informed consent, and comply to
             study procedure, adequate contraception, post-menopausal or abstinent, PANSS Total
             Score equal or greater than 70, score of 4 or greater on two psychotic items

        Exclusion Criteria:

          -  clinically significant, uncontrollable or unstable medical condition, mental
             retardation or severe organic brain syndrome, significant risk of suicide or violent
             behavior
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uriel Heresco-Levy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzog Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>andrea durrant, PhD</last_name>
    <phone>972527181489</phone>
    <email>andy007israel@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Uriel Heresco-Levy, MD</last_name>
    <phone>97225316906</phone>
    <email>urielh@ekmd.huji.ac.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Herzog Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>91035</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Durrant, PhD</last_name>
      <phone>972527181489</phone>
      <email>andy007israel@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Uriel Heresco-Levy, MD</last_name>
      <phone>97225316906</phone>
      <email>urielh@ekmd.huji.ac.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2018</study_first_posted>
  <last_update_submitted>October 9, 2018</last_update_submitted>
  <last_update_submitted_qc>October 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Herzog Hospital</investigator_affiliation>
    <investigator_full_name>Heresco-Levi Uriel</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

